This project considers the involvement of induced immunogenicity in the cure and prevention of rat glioblastoma in the brain as well as the cure and prevention of hepatocarcinoma. We plan to inject parental glioma C6 cells into rat brain. After the tumor is established, transfected cells expressing insulin-like growth factor-I (IGF-I) antisense RNA will be injected either directly into the brain tumor or subcutaneously at a distal site. Such treatment cures experimentally established subcutaneous and brain glioblastoma tumors via an immune response. Therefore, brain tumors will be analyzed by immunocytochemistry for the identification of the immune system cell types participating in the cure in three additional rodent glioblastoma cell lines with an established tumors in the syngeneic animal in order to determine the generality of the phenomenon. The possibility that irradiated cells (incapable of division) can activate the immune system in other cell lines as they do with C6 cells will be studied with all additional cell lines. Glioma cells transfected with antisense vector blocking the expression of IGF type-I receptor will be generated and injected to test whether the receptor participates in an intracrine mechanism(s) underlying tumorigenicity and immunogenicity. The interrelationships between the expression of IGF-I and the major histocompatibility complex-I (MHC-I) will be followed. Other participants in immune recognition, such as cell surface and soluble co-stimulatory molecules, will be assessed. Severe Combined Immune Deficiency (SCID) mice will be implanted with patients lymphocytes in mice carrying glioblastoma tumor of the same donor. This system will he used to study immunogenicity of transfected tumor cells expressing antisense IGF-I cDNA. The second model system, hepatocell carcinoma (generated by the BRL-3A cell line) will also be studied. These cells express IGF-II as does fetal liver. They will be transfected with antisense episome-based IGF-II plasmid and the tumorigenicity and ability to involve the immune response in vivo will be studied. The potential role of IGF receptors in altered tumor cell immunogenicity will be evaluated through antisense gene transfer by a double transfection with IGF type-I and type-II receptors.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Pathology A Study Section (PTHA)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Case Western Reserve University
Schools of Medicine
United States
Zip Code
Shevelev, A; Burfeind, P; Schulze, E et al. (1997) Potential triple helix-mediated inhibition of IGF-I gene expression significantly reduces tumorigenicity of glioblastoma in an animal model. Cancer Gene Ther 4:105-12
Rininsland, F; Johnson, T R; Chernicky, C L et al. (1997) Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells. Proc Natl Acad Sci U S A 94:5854-9
Chernicky, C L; Tan, H; Burfeind, P et al. (1996) Sequence of interleukin-2 isolated from human placental poly A+ RNA: possible role in maintenance of fetal allograft. Mol Reprod Dev 43:180-6
Burfeind, P; Chernicky, C L; Rininsland, F et al. (1996) Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc Natl Acad Sci U S A 93:7263-8
Trojan, J; Naval, X; Johnson, T et al. (1995) Expression of serum albumin and of alphafetoprotein in murine normal and neoplastic primitive embryonic structures. Mol Reprod Dev 42:369-78
Lamande, N; Brosset, S; Lucas, M et al. (1995) Transcriptional up-regulation of the mouse gene for the muscle-specific subunit of enolase during terminal differentiation of myogenic cells. Mol Reprod Dev 41:306-13
Trojan, J; Johnson, T R; Rudin, S D et al. (1994) Gene therapy of murine teratocarcinoma: separate functions for insulin-like growth factors I and II in immunogenicity and differentiation. Proc Natl Acad Sci U S A 91:6088-92